MGI Pharma initiates phase II study of MGI-114 in pancreatic cancer patients Nov. 25, 1998 No Comments
New agents for glioblastoma in preclinical testing at Wayne Hughes Institute Nov. 24, 1998 No Comments
Acadia reaches milestone in Allergan collaboration and first clinical candidate is selected Nov. 24, 1998 No Comments
Mechanism of action of CI-958, a potential agent for prostate cancer in phase II trials Nov. 24, 1998 No Comments
Parke-Davis identifies potent inhibitor of PDGF receptor TK and PDGF-dependent tumor growth Nov. 20, 1998 No Comments
Vertex reports preliminary data on Incel in soft tissue carcinoma and initiates new phase II trial Nov. 20, 1998 No Comments